APOE and metabolic syndrome: Because the production of apoE is one of the important determinants for the secretion of VLDL or VLDL-TG from the liver [3], the upregulation of apoE gene together with the increased production of triglycerides [17,18] by LXR activation facilitates the production of VLDL particles, resulting in the atherogenic lipid profile of the metabolic syndrome.